September 29, 2022

Volume XII, Number 272

Advertisement

September 29, 2022

Subscribe to Latest Legal News and Analysis

September 28, 2022

Subscribe to Latest Legal News and Analysis

September 27, 2022

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
29
Sep
FDCA’s Exclusive Enforcement Provision Reigns Supreme over State Laws McDermott Will & Emery
29
Sep
What’s Important About Federal Registration of Bank Trademarks Jones Walker LLP
29
Sep
Warby Parker Beats Back 1-800's Infringement Claims Katten
29
Sep
PTO Switches to New Public Search Tools, New PTAB Filing System McDermott Will & Emery
28
Sep
The #AD Vantage Point: Navigating the FTC Endorsement Guides, Part I Ward and Smith, P.A.
27
Sep
Type C Patent Term Adjustment Requires Fully Successful Appeal Foley & Lardner LLP
27
Sep
Colorado Continues to Whittle Away at Non-compete Agreements McDermott Will & Emery
26
Sep
Pennywise and Pound Foolish: Default Judgment Entered Against Trade Secret Defendants as a Sanction for Inadequate E-Discovery Epstein Becker & Green, P.C.
24
Sep
Names and Brand Names Norris McLaughlin P.A.
23
Sep
Reminder: Extended CNIPA Closure for Chinese National Day Schwegman, Lundberg & Woessner, P.A.
23
Sep
Spilling Secrets - Employers: Train on Trade Secrets [PODCAST] Epstein Becker & Green, P.C.
23
Sep
Just Humor Them in Infringement and Defamation Cases Epstein Becker & Green, P.C.
22
Sep
Ninth Circuit Provides Clarity on the Scope of Receiverships McDermott Will & Emery
22
Sep
Sometimes Inactions Speak Louder Than Words McDermott Will & Emery
22
Sep
Nothing Private about Relator’s Qui Tam Action Info McDermott Will & Emery
22
Sep
CAFC Pulls Final Loose Thread in Nike-Adidas Patent Row McDermott Will & Emery
22
Sep
Claim at Issue Must Be Substantively Allowable to Qualify for PTA McDermott Will & Emery
22
Sep
No Second Bite at the Apple: Dismissal under Duplicative-Litigation Doctrine McDermott Will & Emery
22
Sep
It Can Take Three Appeals to Make a Claim Construction Go “Right”—or Three Bites by Apple McDermott Will & Emery
22
Sep
Too Quick to Be Lit—Need to Serve That Complaint First McDermott Will & Emery

Pages

Advertisement
Advertisement
Advertisement